510(k) K262839

Cleerly ISCHEMIA by Cleerly, Inc. — Product Code QXZ

K262839 is an FDA 510(k) premarket notification submitted by Cleerly, Inc. for the device "Cleerly ISCHEMIA". The FDA issued a decision of Substantially Equivalent on Oct 29, 2026. The device falls under product code QXZ (Adjunctive Epicardial Vascular Physiologic Status Indicator), a Class II device regulated under 21 CFR 870.2200. Cleerly, Inc. has 6 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Oct 29, 2026
Date Received
Aug 11, 2026
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Adjunctive Epicardial Vascular Physiologic Status Indicator
Device Class
Class II
Regulation Number
870.2200
Review Panel
CV
Submission Type
510(k)

The adjunctive epicardial vascular physiologic status indicator is a prescription device based on sensor technology or image data to provide information to an interpreting clinician in detecting the possible presence of functionally significant coronary artery disease to suggest the need for further testing. This device is intended for adjunctive use with other clinical workup or patient information and is not intended to quantify the degree to which epicardial disease is limiting flow through a vessel nor is it intended to independently direct therapy.

Need the full FDA record for Cleerly, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K262839. Report a data issue: hello@regdatalab.com.